BioCorRx Inc (BICX)
OTHER OTC:BICX
Total Valuation
BioCorRx has a market cap or net worth of $10.56M. The enterprise value is $9.41M.
Market Cap$10.56M
Enterprise Value$9.41M
Share Statistics
BioCorRx has 26,402,874 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding26,402,874
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
BioCorRx’s return on equity (ROE) is 0.31 and return on invested capital (ROIC) is 112.37%.
Return on Equity (ROE)0.31
Return on Assets (ROA)-1.60
Return on Invested Capital (ROIC)112.37%
Return on Capital Employed (ROCE)0.78
Revenue Per Employee265.75K
Profits Per Employee-1.17M
Employee Count3
Asset Turnover0.37
Inventory Turnover0.15
Valuation Ratios
The current PE Ratio of BioCorRx is ―. BioCorRx’s PEG ratio is 0.03.
PE Ratio―
PS Ratio6.75
PB Ratio-0.48
Price to Fair Value-0.48
Price to FCF-2.34
Price to Operating Cash Flow-2.07
PEG Ratio0.03
Income Statement
In the last 12 months, BioCorRx had revenue of 797.24K and earned -3.44M in profits. Earnings per share was -0.19.
Revenue797.24K
Gross Profit775.44K
Operating Income-4.83M
Pretax Income-3.51M
Net Income-3.44M
EBITDA-2.56M
Earnings Per Share (EPS)-0.19
Cash Flow
In the last 12 months, operating cash flow was -2.30M and capital expenditures 3.00, giving a free cash flow of -2.30M billion.
Operating Cash Flow-2.30M
Free Cash Flow-2.30M
Free Cash Flow per Share-0.09
Dividends & Yields
BioCorRx pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.43
52-Week Price Change-18.37%
50-Day Moving Average0.35
200-Day Moving Average0.37
Relative Strength Index (RSI)59.29
Average Volume (3m)824.00
Important Dates
BioCorRx upcoming earnings date is Aug 17, 2026, TBA (Confirmed).
Last Earnings DateAug 14, 2025
Next Earnings DateAug 17, 2026
Ex-Dividend Date―
Financial Position
BioCorRx as a current ratio of 0.10, with Debt / Equity ratio of -18.97%
Current Ratio0.10
Quick Ratio0.08
Debt to Market Cap0.37
Net Debt to EBITDA-0.78
Interest Coverage Ratio-5.61
Taxes
In the past 12 months, BioCorRx has paid -68.62K in taxes.
Income Tax-68.62K
Effective Tax Rate0.02
Enterprise Valuation
BioCorRx EV to EBITDA ratio is -2.88, with an EV/FCF ratio of -3.21.
EV to Sales9.25
EV to EBITDA-2.88
EV to Free Cash Flow-3.21
EV to Operating Cash Flow-3.21
Balance Sheet
BioCorRx has $139.36K in cash and marketable securities with $2.13M in debt, giving a net cash position of -$1.99M billion.
Cash & Marketable Securities$139.36K
Total Debt$2.13M
Net Cash-$1.99M
Net Cash Per Share-$0.08
Tangible Book Value Per Share-$0.68
Margins
Gross margin is 88.24%, with operating margin of -606.04%, and net profit margin of -431.50%.
Gross Margin88.24%
Operating Margin-606.04%
Pretax Margin-440.11%
Net Profit Margin-431.50%
EBITDA Margin-321.50%
EBIT Margin-332.04%
Analyst Forecast
The average price target for BioCorRx is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast3464.86%
EPS Growth Forecast38.01%